Taketani Yutaka, Koiwa Fumihiko, Yokoyama Keitaro
Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):27-36. doi: 10.1007/s10157-016-1360-y. Epub 2016 Nov 28.
Disturbances in mineral and bone metabolism play a critical role in the pathogenesis of cardiovascular complications in patients with chronic kidney disease (CKD). The term "renal osteodystrophy" has recently been replaced with "CKD-mineral and bone disorder (CKD-MBD)", which includes vascular calcification as well as bone abnormalities. In Japan, proportions of the aged and long-term dialysis patients are increasing which makes management of vascular calcification and parathyroid function increasingly more important. There are three main strategies to manage phosphate load: phosphorus dietary restriction, administration of phosphate binder and to ensure in the CKD 5D setting, an adequate dialysis.
矿物质和骨代谢紊乱在慢性肾脏病(CKD)患者心血管并发症的发病机制中起关键作用。术语“肾性骨营养不良”最近已被“CKD-矿物质和骨紊乱(CKD-MBD)”所取代,后者包括血管钙化以及骨异常。在日本,老年人和长期透析患者的比例正在增加,这使得血管钙化和甲状旁腺功能的管理变得越来越重要。管理磷负荷有三种主要策略:限制饮食中的磷、给予磷结合剂以及在CKD 5D阶段确保充分透析。